Dysregulation of vitamin D synthesis pathway genes in colorectal cancer: A case-control study

Background: The cytochromes P450 are a superfamily of enzymes that control the synthesis of the biologically active form of vitamin D, 1,25-dihydroxyvitamin D3. These enzymes contribute to the formation of 1,25-dihydroxyvitamin D3, which starts with a 25-hydroxylation by CYP2R1 and CYP27A1 and a sub...

Full description

Bibliographic Details
Main Authors: Aghaei, N. (Author), Asadzadeh Aghdaei, H. (Author), Kamaliyan, Z. (Author), Mirfakhraie, R. (Author), Mohseni, R. (Author), Moshiri, A. (Author), Nazemalhosseini-Mojarad, E. (Author), Sadeghi, H. (Author), Sahebi, U. (Author), Zali, M.R (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04756nam a2200985Ia 4500
001 10.1002-jcla.23617
008 220427s2021 CNT 000 0 und d
020 |a 08878013 (ISSN) 
245 1 0 |a Dysregulation of vitamin D synthesis pathway genes in colorectal cancer: A case-control study 
260 0 |b John Wiley and Sons Inc  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/jcla.23617 
520 3 |a Background: The cytochromes P450 are a superfamily of enzymes that control the synthesis of the biologically active form of vitamin D, 1,25-dihydroxyvitamin D3. These enzymes contribute to the formation of 1,25-dihydroxyvitamin D3, which starts with a 25-hydroxylation by CYP2R1 and CYP27A1 and a subsequent 1α-hydroxylation via CYP27B1. Methods: By using quantitative real-time polymerase chain reaction (qRT-PCR), we analyzed the expression ratio of CYP2R1, CYP27A1 and CYP27B1 genes within the vitamin D metabolic pathway in a total of 75 colorectal cancer (CRC) tissues compared to the adjacent tissues. Furthermore, we evaluated the association of CYP27B1 rs4646536 and CYP2R1 rs12794714 and rs10766196 polymorphisms with CRC risk in a total of 490 subjects, including 245 CRC patients and 245 non-cancer controls. The genotyping was performed using tetra-primer amplification refractory mutation system polymerase chain reaction (TP-ARMS–PCR) method. Results: The results indicated 2.3 and 2.7 upregulation of CYP2R1 and CYP27B1 genes in colorectal cancer tissues compared to the adjacent tissues, respectively. Rs12794714 AG genotype increased the risk of CRC (P =.03). Furthermore, a significant association was observed under the dominant inheritance model (P =.039). Conclusion: CYP2R1 and CYP27B1 genes were over-expressed in CRC samples compared to the adjacent control tissues. Furthermore, CYP2R1 rs12794714 variant was associated with the risk of CRC in the studied samples. CYP2R1 rs10766196 and CYP27B1 rs4646536 are not responsible for CYP2R1 and CYP27B1 genes expression alteration, respectively, but CYP2R1 rs12794714 polymorphism may be the reason of CYP2R1 upregulation and increased the risk of CRC. © 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC 
650 0 4 |a 25-Hydroxyvitamin D3 1-alpha-Hydroxylase 
650 0 4 |a adult 
650 0 4 |a aged 
650 0 4 |a Aged 
650 0 4 |a Article 
650 0 4 |a biosynthesis 
650 0 4 |a calcidiol 1 monooxygenase 
650 0 4 |a case control study 
650 0 4 |a Case-Control Studies 
650 0 4 |a cholestanetriol 26 monooxygenase 
650 0 4 |a cholestanetriol 26 monooxygenase 
650 0 4 |a Cholestanetriol 26-Monooxygenase 
650 0 4 |a colorectal cancer 
650 0 4 |a colorectal cancer 
650 0 4 |a Colorectal Neoplasms 
650 0 4 |a colorectal tumor 
650 0 4 |a controlled study 
650 0 4 |a CYP27A1 gene 
650 0 4 |a CYP27A1 protein, human 
650 0 4 |a CYP27B1 
650 0 4 |a CYP27B1 gene 
650 0 4 |a CYP27B1 protein, human 
650 0 4 |a CYP2R1 
650 0 4 |a CYP2R1 gene 
650 0 4 |a CYP2R1 protein, human 
650 0 4 |a cytochrome P450 family 2 
650 0 4 |a Cytochrome P450 Family 2 
650 0 4 |a DNA extraction 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a gene 
650 0 4 |a gene expression 
650 0 4 |a gene expression regulation 
650 0 4 |a Gene Expression Regulation, Neoplastic 
650 0 4 |a gene frequency 
650 0 4 |a Gene Frequency 
650 0 4 |a genetic association 
650 0 4 |a genetic risk 
650 0 4 |a genetics 
650 0 4 |a genotype 
650 0 4 |a human 
650 0 4 |a human tissue 
650 0 4 |a Humans 
650 0 4 |a Iranian people 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a metabolism 
650 0 4 |a middle aged 
650 0 4 |a Middle Aged 
650 0 4 |a pathology 
650 0 4 |a Polymorphism, Single Nucleotide 
650 0 4 |a population research 
650 0 4 |a real time polymerase chain reaction 
650 0 4 |a single nucleotide polymorphism 
650 0 4 |a single-nucleotide polymorphism 
650 0 4 |a tetra primer amplification refractory mutation system polymerase chain reaction 
650 0 4 |a upregulation 
650 0 4 |a vitamin D 
650 0 4 |a vitamin D 
650 0 4 |a vitamin D 
650 0 4 |a Vitamin D 
700 1 |a Aghaei, N.  |e author 
700 1 |a Asadzadeh Aghdaei, H.  |e author 
700 1 |a Kamaliyan, Z.  |e author 
700 1 |a Mirfakhraie, R.  |e author 
700 1 |a Mohseni, R.  |e author 
700 1 |a Moshiri, A.  |e author 
700 1 |a Nazemalhosseini-Mojarad, E.  |e author 
700 1 |a Sadeghi, H.  |e author 
700 1 |a Sahebi, U.  |e author 
700 1 |a Zali, M.R.  |e author 
773 |t Journal of Clinical Laboratory Analysis